Viewing Study NCT00085332


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-01-01 @ 1:36 PM
Study NCT ID: NCT00085332
Status: COMPLETED
Last Update Posted: 2014-01-13
First Post: 2004-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
Sponsor: Gynecologic Oncology Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: GOG-0129N
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View